Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 009 JPY -0.79% Market Closed
Market Cap: 30.8B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Daito Pharmaceutical Co Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Retained Earnings
ÂĄ36.4B
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
14%
Takeda Pharmaceutical Co Ltd
TSE:4502
Retained Earnings
ÂĄ1.4T
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
-3%
Daiichi Sankyo Co Ltd
TSE:4568
Retained Earnings
ÂĄ1.5T
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
7%
Otsuka Holdings Co Ltd
TSE:4578
Retained Earnings
ÂĄ1.7T
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Retained Earnings
ÂĄ1.5T
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
13%
Astellas Pharma Inc
TSE:4503
Retained Earnings
ÂĄ818B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
-1%
No Stocks Found

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
30.7B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
2 429.67 JPY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Daito Pharmaceutical Co Ltd's Retained Earnings?
Retained Earnings
36.4B JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Retained Earnings amounts to 36.4B JPY.

What is Daito Pharmaceutical Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
14%

Over the last year, the Retained Earnings growth was 3%. The average annual Retained Earnings growth rates for Daito Pharmaceutical Co Ltd have been 7% over the past three years , 11% over the past five years , and 14% over the past ten years .

Back to Top